Separately, a bipartisan coalition of state attorney generals have urged acting FDA Commissioner Sara Brenner to act on scammers and counterfeit GLP-1 drugs they say are infiltrating the supply chain, though the group did not refer specifically to the Partnership for Safe Medicines report
Should I switch from semaglutide to retatrutide instead of combining them
Once removed from shortage status, compounding becomes more legally precarious, potentially reducing availability and increasing costs
GLP-1 drug usage was associated with a reduced risk of just about everything bad: substance use and psychotic disorders, seizures, neuro-cognitive disorders (including Alzheimers disease and dementia), coagulation disorders [e.g., means clotting], cardio-metabolic disorders, infectious illnesses and several respiratory conditions. When I initially read this study in January, it seemed too good to be true
Snacks String Cheese: A convenient high-protein snack thats easy to carry